GUANGZHOU WONDFO BIOTECH CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.12 CNY | -2.82% |
|
-4.49% | -16.74% |
| 05-06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
| 04-21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Guangzhou Wondfo Biotech Co.,Ltd
Price target over the last 5 years
History of analyst recommendation changes
58aeec2e859063581d.cSAeDYIEkCpOASwzTxN-sJb9xJyIEehM4GJbcS8vXHs.EGtVRdphpngiRVRJN1A19MGWlqvkSYwDjDp2J39_bg8lSnxJ7EeodRlKHA~d2ee4e0c82bcd99f5b33aa7469c2f0d7
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
25.12
CNY
Average target price
36.3
CNY
Spread / Average Target
+44.49%
High Price Target
38.59
CNY
Spread / Highest target
+53.62%
Low Price Target
34
CNY
Spread / Lowest Target
+35.35%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 300482 Stock
- Consensus Guangzhou Wondfo Biotech Co.,Ltd
